Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1982 Dec;58(6):381–386. doi: 10.1136/sti.58.6.381

Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.

G R Skinner, C B Woodman, C E Hartley, A Buchan, A Fuller, J Durham, M Synnott, J C Clay, J Melling, C Wiblin, J Wilkins
PMCID: PMC1046107  PMID: 6293640

Abstract

A subunit antigenoid vaccine, Ac NFU1 (S-) MRC, was used to prevent primary herpes genitalis in 60 subjects considered to be at risk of this infection. There was no evidence of serious local or general side effects. Neutralising antibody responses were detected in 59% and 90% of subjects receiving the low and high doses of vaccine respectively; immunoprecipitating antibody was detected at a lower frequency, namely in 23% and 43% of subjects receiving the low and high doses respectively. After a mean follow-up period of 18 months none of the vaccinated subjects contracted herpes genitalis after completing the vaccination course.

Full text

PDF
381

Images in this article

383Image
on p.383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON S. G., HAMILTON J., WILLIAMS S. An attempt to vaccinate against herpes simplex. Aust J Exp Biol Med Sci. 1950 Sep;28(5):579–584. doi: 10.1038/icb.1950.58. [DOI] [PubMed] [Google Scholar]
  2. Adam E., Kaufman R. H., Melnick J. L., Levy A. H., Rawls W. E. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. IV. Dysplasia and carcinoma in situ. Am J Epidemiol. 1973 Aug;98(2):77–87. doi: 10.1093/oxfordjournals.aje.a121541. [DOI] [PubMed] [Google Scholar]
  3. Asher L. V., Walz M. A., Notkins A. L. Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2. Am J Obstet Gynecol. 1978 Aug 1;131(7):788–791. doi: 10.1016/0002-9378(78)90248-x. [DOI] [PubMed] [Google Scholar]
  4. Benda R., Dbalý V. Immunogenic properties of formalin herpes antigen prepared from cell cultures. J Hyg Epidemiol Microbiol Immunol. 1973;17(2):237–249. [PubMed] [Google Scholar]
  5. Blank H., Haines H. G. Experimental human reinfection with herpes simplex virus. J Invest Dermatol. 1973 Oct;61(4):223–225. doi: 10.1111/1523-1747.ep12676442. [DOI] [PubMed] [Google Scholar]
  6. Carter C. A., Hartley C. E., Skinner G. R., Turner S. P., Easty D. L. Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine. Br J Ophthalmol. 1981 Oct;65(10):679–682. doi: 10.1136/bjo.65.10.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. GOLDMAN L. Reactions of autoinoculation for recurrent herpes simplex. Arch Dermatol. 1961 Dec;84:1025–1026. doi: 10.1001/archderm.1961.01580180141022. [DOI] [PubMed] [Google Scholar]
  8. Heine J. W., Honess R. W., Cassai E., Roizman B. Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains. J Virol. 1974 Sep;14(3):640–651. doi: 10.1128/jvi.14.3.640-651.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LAZAR M. P. Vaccination for recurrent herpes simplex infection; initiation of a new disease site following the use of unmodified material containing the live virus. AMA Arch Derm. 1956 Jan;73(1):70–71. doi: 10.1001/archderm.1956.01550010072010. [DOI] [PubMed] [Google Scholar]
  10. MACPHERSON I., STOKER M. Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence. Virology. 1962 Feb;16:147–151. doi: 10.1016/0042-6822(62)90290-8. [DOI] [PubMed] [Google Scholar]
  11. McKendall R. R. Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice. Infect Immun. 1977 May;16(2):717–719. doi: 10.1128/iai.16.2.717-719.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Naib Z. M., Nahmias A. J., Josey W. E. Cytology and histopathology of cervical herpes simplex infection. Cancer. 1966 Jul;19(7):1026–1031. doi: 10.1002/1097-0142(196607)19:7<1026::aid-cncr2820190718>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  13. Powell K. L., Buchan A., Sim C., Watson D. H. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody. Nature. 1974 May 24;249(455):360–361. doi: 10.1038/249360a0. [DOI] [PubMed] [Google Scholar]
  14. Sim C., Watson D. H. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. J Gen Virol. 1973 May;19(2):217–233. doi: 10.1099/0022-1317-19-2-217. [DOI] [PubMed] [Google Scholar]
  15. Skinner G. R., Buchan A., Hartley C. E., Turner S. P., Williams D. R. The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects. Med Microbiol Immunol. 1980;169(1):39–51. doi: 10.1007/BF02123711. [DOI] [PubMed] [Google Scholar]
  16. Skinner G. R., Taylor J., Edwards J. Precipitating antibodies to herpes simplex virus in human sera: prevalence of antibody to common antigen (band II). Intervirology. 1974;4(5):320–324. doi: 10.1159/000149865. [DOI] [PubMed] [Google Scholar]
  17. Skinner G. R. Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism. Br J Exp Pathol. 1976 Aug;57(4):361–376. [PMC free article] [PubMed] [Google Scholar]
  18. Skinner G. R., Whitney J. E., Hartley C. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects. Arch Virol. 1977;54(3):211–221. doi: 10.1007/BF01314787. [DOI] [PubMed] [Google Scholar]
  19. Skinner G. R., Williams D. R., Buchan A., Whitney J., Harding M., Bodfish K. Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection. Med Microbiol Immunol. 1978 Nov 17;166(1-4):119–132. doi: 10.1007/BF02121141. [DOI] [PubMed] [Google Scholar]
  20. Thouless M. E., Skinner G. R. Differences in the properties of thymidine kinase produced in cells infected with type 1 and type 2 herpes virus. J Gen Virol. 1971 Aug;12(2):195–197. doi: 10.1099/0022-1317-12-2-195. [DOI] [PubMed] [Google Scholar]
  21. Walz M. A., Price R. W., Hayashi K., Katz B. J., Notkins A. L. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis. 1977 May;135(5):744–752. doi: 10.1093/infdis/135.5.744. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES